佛芍颗粒对功能性腹痛模型小鼠的治疗作用研究

doi:10.19803/j.1672-8629.20230285

中国药物警戒 ›› 2024, Vol. 21 ›› Issue (3): 269-272.
DOI: 10.19803/j.1672-8629.20230285

• 基于多模型、多靶点的中药抗感染药效及机制研究专栏（二） • 上一篇下一篇

佛芍颗粒对功能性腹痛模型小鼠的治疗作用研究

李舒冉¹, 郭姗姗¹, 包蕾¹, 孙静¹, 赵荣华¹, 鲍岩岩¹, 耿子涵¹, 张宇¹, 曹姗¹, 吕耀中^2,3, 王振中^2,3, 崔晓兰^1,*, 王红梅^2,3,#

¹中国中医科学院中药研究所生物安全实验室,北京 100700;
²中药制药过程控制与智能制造技术全国重点实验室,江苏连云港 222000;
³江苏康缘药业股份有限公司,江苏连云港 222000

收稿日期:2023-05-09 出版日期:2024-03-15 发布日期:2024-03-18
通讯作者: ^*崔晓兰,女,博士,研究员·博导,中药防治感染性疾病机制研究。E-mail: xlcui@icmm.ac.cn;^#为共同通信作者。
作者简介:李舒冉,女,博士,助理研究员,中药防治感染性疾病机制研究。
基金资助:
国家自然科学基金资助项目（82141206）; 中央级公益性科研院所基本科研业务费专项资金资助（ZZ15-YQ-035; ZXKT21031）; 中国中医科学院科技创新项目（CI2021B015）

Therapeutic effect of Foshao granules in mice with functional abdominal pain

LI Shuran¹, GUO Shanshan¹, BAO Lei¹, SUN Jing¹, ZHAO Ronghua¹, BAO Yanyan¹, GENG Zihan¹, ZHANG Yu¹, CAO Shan¹, LYU Yaozhong^2,3, WANG Zhenzhong^2,3, CUI Xiaolan^1,*, WANG Hongmei^2,3,#

¹Biosecurity Laboratory, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China;
²National Key Laboratory of Process Control and Intelligent Manufacturing Technology of Traditional Chinese Medicine Pharmaceuticals, Lianyungang Jiangsu 222000, China;
³Jiangsu Kangyuan Pharmaceutical Co., Ltd, Lianyungang Jiangsu 222000, China

Received:2023-05-09 Online:2024-03-15 Published:2024-03-18

摘要/Abstract

摘要： 目的明确佛芍颗粒对功能性腹痛模型小鼠的治疗作用,为临床应用提供基础研究数据支持。方法实验小鼠按体质量随机分为正常对照组、模型对照组、吗丁啉对照组（12 mg·kg^-1）、四逆散对照组（3 g·kg^-1）、佛芍颗粒高剂量组（48 g生药·kg^-1）、佛芍颗粒中剂量组（24 g生药·kg^-1）、佛芍颗粒低剂量组（12 g生药·kg^-1）7 组,每组10只,雌雄各半。采用寒冷刺激结合腹腔注射福尔马林制备寒凝气滞功能性腹痛病证结合模型,通过检测小鼠疼痛潜伏期、疼痛时长、疼痛发生率及结肠组织病理变化等指标综合评价佛芍颗粒对功能性腹痛小鼠的治疗作用。结果佛芍颗粒可以明显延长疼痛潜伏期（P<0.05,P<0.01）、缩短疼痛持续时间、降低疼痛发生率,减轻小鼠结肠黏膜增生及炎症等。结论佛芍颗粒可以改善寒冷刺激结合福尔马林诱导的寒凝气滞功能性腹痛病证结合模型小鼠的腹痛,为佛芍颗粒的临床应用提供参考。

关键词: 功能性腹痛, 寒凝气滞证, 佛芍颗粒, 治疗作用, 小鼠

Abstract: Objective To clarify the therapeutic effect of Foshao granules in mice with spastic abdominal pain, and provide basic research data support for clinical application. Methods Experimental mice were randomly divided into seven groups according to their body weight: the normal control group, model control group, Domperidone control group (12 mg·kg^-1), Sini Powdered control group (3 g·kg^-1), Foshao granules high dosage group (48 g crude drug·kg^-1), Foshao granules middle dosage group (24 g crude drug·kg^-1), Foshao granules low dosage group (12 g crude drug·kg^-1), with 10 mice in each group. A cold stagnation functional abdominal painmedical syndrome combination model made by cold stimulation combined with an intraperitoneal injection of formalin. The therapeutic effect of mice with spastic abdominal pain induced by neostigmine was evaluated with the pain latency, the pain incidence, duration of pain, the pathological changes in the colon of the mice. Results The Foshao granules can significantly reduce the incidence of pain, prolong the pain incubation (P<0.05, P<0.01), shorten the pain length, and reduce the mucosal hyperplasia, and the enlargement and increase of goblet cells in the interstitial inflammation machine in the colon. Conclusion The Foshao granules significantly improved cold stimulation combined with formalin-induced functional abdominal pain in mice, providing a reference for the clinical application of Foshao granules.

Key words: neostigmine, spastic abdominal pain, Foshao granules, therapeutical effect, mice

中图分类号:

R994.1

李舒冉, 郭姗姗, 包蕾, 孙静, 赵荣华, 鲍岩岩, 耿子涵, 张宇, 曹姗, 吕耀中, 王振中, 崔晓兰, 王红梅. 佛芍颗粒对功能性腹痛模型小鼠的治疗作用研究[J]. 中国药物警戒, 2024, 21(3): 269-272.

LI Shuran, GUO Shanshan, BAO Lei, SUN Jing, ZHAO Ronghua, BAO Yanyan, GENG Zihan, ZHANG Yu, CAO Shan, LYU Yaozhong, WANG Zhenzhong, CUI Xiaolan, WANG Hongmei. Therapeutic effect of Foshao granules in mice with functional abdominal pain[J]. Chinese Journal of Pharmacovigilance, 2024, 21(3): 269-272.

导出引用管理器 EndNote|Ris|BibTeX

链接本文: https://www.zgywjj.com/CN/10.19803/j.1672-8629.20230285

https://www.zgywjj.com/CN/Y2024/V21/I3/269

参考文献

[1] LAURIE K, DOUGLAR AD, ELESPETH G, et al.Centrally mediated disorders of gastrointestinal pain[J]. Gastroenterology, 2016, 150(6): 1408-1419.
[2] FU JJ, WANG J, DUAN YH, et al.Meta-analysis of functional abdominal pain in children from spleen treatment prescription[J]. Journal of China-Japan Friendship Hospital(中日友好医院学报 ), 2021, 35(2): 102-104.
[3] NIKHIL T, MARC AB, MICHAEL DC, et al.Paediatric function abdominal pain disorders[J]. Nat Rev Dis Primers, 2020, 6(1): 89.
[4] KAPURAL L, GUPTA M, PAICIUS R, et al.Treatment of chronic abdominal pain with 10-kHz spinal cord stimulation: safety and efficaay results from a 12-Month prospective, multicenter, feasibility study[J]. Clin Transl Gastroenterol, 2020, 11(2): e133.
[5] DINAN TG, CRYAN JF.The microbiome-gut-brain axis in health and disease[J]. gastroenterol Clin North Am, 2017, 46(1): 77-89.
[6] GUO Y, SU XL, WEI W.Diagnosis and treatment progress of Chinese and western medicine in functional a bdominal pain syndrome[J]. Chinese Archives of Traditional Chinese Medicine(中国中医药学刊),2016,34(5): 1077-1080.
[7] MA JM, CHEN L.Research progress of TCM treatment for functional abdominal pain in children[J]. Chinese Pediatrics of Integrated Traditional and Western Medicine(中国中西医结合儿科学), 2017, 9(4): 293-295.
[8] ZHAO WJ.Analysis of the predominant intestinal flora changes in patients with functional abdominal pain syndrome[D].Qingdao: University Of Qingdao(青岛大学), 2019.
[9] AGNETA U, JOHAN A, FRANK L, et al.Irritable bowel syndrome and functional abdominal pain in five-year-old children are related to lifestyle[J]. Acta Paediatr, 2016, 105(8): 971-978.
[10] HUANG MG, WANG JX, LUO F, et al.Pathogenesis of functional abdominal pain syndrome and research of traditional Chinese medicine intervention[J]. Journal of Liaoning University of Traditional Chinese Medicine(辽宁中医药大学学报), 2023, 25(7): 176-181.
[11] WANG QQ, ZHANG XL, LI MY, et al.Progress in TCM clinical studies of pediatric functional abdominal pain[J]. Journal of Hebei Traditional Chinese Medicine and Pharmacology(河北中医药学报), 2019, 34(3): 58-61.
[12] WEN TY, LIU XS.Professor Liu Xingshan's experience in treating and treating functional abdominal pain[J]. World Latest Medicine Information(世界最新医学信息文摘) , 2019, 19(28): 215.
[13] HOU F, SONG S.Clinical observation of 41 cases of functional abdominal pain and liver stagnation in children with integrated Chinese and Western medicine[J].Journal of Pediatrics of Traditional Chinese Medicine(中医儿科杂志), 2019, 15(3): 58-61.
[14] WANG JG, LI HN.From the "SuWen, The pain theory" on the lumbar disc herniation pain syndrome of massage syndrome treatment ideas[J]. Liaoning Journal of Traditional Chinese Medicine(辽宁中医杂志), 2015, 42(11): 2125-2127.
[15] HANG PJ, ZHANG D.Professor Zhang Di's experience in the treatment of functional abdominal pain in children extracted[J].Journal of Hunan University of Chinese Medicine(湖南中医药大学学报), 2020, 40(5): 613-616.

佛芍颗粒对功能性腹痛模型小鼠的治疗作用研究

Therapeutic effect of Foshao granules in mice with functional abdominal pain

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	姚伟洁, 闫仕祺, 袁偲偲, 贡磊磊, 冯欣. 养血安胎方对复发性自然流产小鼠胎盘血管生成与自噬的调控作用研究[J]. 中国药物警戒, 2024, 21(4): 371-377.
[2]	李舒冉, 郭姗姗, 包蕾, 赵荣华, 孙静, 耿子涵, 鲍岩岩, 张敬升, 徐英利, 吕耀中, 王振中, 崔晓兰, 王红梅. 佛芍颗粒对新斯的明致大鼠痉挛性腹痛的作用研究[J]. 中国药物警戒, 2024, 21(4): 404-407.
[3]	黄曙光, 张学农. 多肽BR0336在小鼠2型糖尿病合并非酒精性脂肪性肝炎模型上的初步药效学研究[J]. 中国药物警戒, 2024, 21(4): 415-421.
[4]	孙绮悦, 郭姗姗, 赵荣华, 包蕾, 耿子涵, 李舒冉, 徐英莉, 张敬升, 崔晓兰, 孙静. 变应性鼻炎相关动物模型研究进展[J]. 中国药物警戒, 2024, 21(3): 241-245.
[5]	孙静, 赵荣华, 郭姗姗, 高双荣, 包蕾, 耿子涵, 李舒冉, 孙绮悦, 徐洲, 覃广源, 潘玉杰, 谭秋霞, 龙忠义, 黄成钢, 崔晓兰. BD-77雾化吸入给药对肺炎支原体感染小鼠的治疗作用[J]. 中国药物警戒, 2024, 21(3): 253-256.
[6]	孙绮悦, 赵荣华, 包蕾, 郭姗姗, 耿子涵, 李舒冉, 徐英莉, 张敬升, 崔晓兰, 孙静. 基于多动物模型药效评价体系研究羚羊感冒口服液儿童用药剂量[J]. 中国药物警戒, 2024, 21(2): 121-126.
[7]	孙绮悦, 赵荣华, 郭姗姗, 包蕾, 耿子涵, 李舒冉, 徐英莉, 张敬升, 崔晓兰, 孙静. 羚羊感冒口服液多重药理作用研究[J]. 中国药物警戒, 2024, 21(2): 127-131.
[8]	赵荣华, 孙静, 包蕾, 耿子涵, 陶夏莉, 张敬升, 庞博, 徐英莉, 曹姗, 李舒冉, 郭姗姗, 王道涵, 崔晓兰. 基于免疫调节探讨葛根汤颗粒治疗小鼠病毒性肺炎的作用机制[J]. 中国药物警戒, 2024, 21(2): 132-136.
[9]	曹姗, 庞博, 徐英莉, 张敬升, 陈梦苹, 张宇, 王雅欣, 包蕾, 耿子涵, 郭姗姗, 赵荣华, 崔晓兰. 疏风解毒胶囊预防给药对流感病毒感染小鼠模型TLR4介导肺组织炎性损伤的影响[J]. 中国药物警戒, 2024, 21(1): 45-50.
[10]	张敬升, 高双荣, 庞博, 刘莉娜, 徐英莉, 曹姗, 陈梦苹, 张宇, 赵荣华, 崔晓兰. 散寒化湿颗粒对人冠状病毒229E和OC43感染致小鼠肺炎的作用机制研究[J]. 中国药物警戒, 2024, 21(1): 51-54.
[11]	张亮亮, 胡昌坤, 吴泽坤, 周维, 廖泽彬, 高月. 富马酸二甲酯对肠道辐射损伤防护作用及机制研究[J]. 中国药物警戒, 2024, 21(1): 83-88.
[12]	殷玉玲, 胡楚涓, 张晓朦, 王雨, 张冰, 林志健. 菊苣提取物抗阿霉素心脏毒性作用挖掘及验证[J]. 中国药物警戒, 2023, 20(8): 858-865.
[13]	梅雨, 朱越, 张慧婷, 肖成荣, 高月, 马增春. 基于网络药理学和实验验证探讨中药复方CB001对低剂量辐射防护的作用机制[J]. 中国药物警戒, 2023, 20(8): 872-879.
[14]	杨明翰, 乔美玲, 骆骄阳, 杨美华, 盛萍. 多伞阿魏抗胃癌活性部位的急性毒性试验研究[J]. 中国药物警戒, 2023, 20(8): 880-884.
[15]	沈宁宁, 刘昱甫, 茹毅, 师卓, 杨春启, 倪喆鑫, 肖成荣, 马增春, 王宇光, 高月. 麦冬皂苷D对小鼠力竭游泳抗疲劳作用的研究[J]. 中国药物警戒, 2023, 20(7): 749-753.